TWD 72.7
(-0.41%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 3.36 Billion TWD | 0.04% |
2022 | 3.36 Billion TWD | -4.59% |
2021 | 3.52 Billion TWD | 7.51% |
2020 | 3.28 Billion TWD | -2.98% |
2019 | 3.38 Billion TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 3.74 Billion TWD | -5.39% |
2024 Q1 | 3.95 Billion TWD | 17.35% |
2023 Q4 | 3.36 Billion TWD | -5.28% |
2023 FY | 3.36 Billion TWD | 0.04% |
2023 Q1 | 3.94 Billion TWD | 17.06% |
2023 Q3 | 3.55 Billion TWD | -3.58% |
2023 Q2 | 3.68 Billion TWD | -6.43% |
2022 Q4 | 3.36 Billion TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Allied Biotech Corporation | 910.11 Million TWD | -270.147% |
GeneFerm Biotechnology Co., Ltd. | 282.53 Million TWD | -1092.324% |
Easywell Biomedicals, Inc. | 589.98 Million TWD | -470.989% |
Synmosa Biopharma Corporation | 3.62 Billion TWD | 7.137% |
Orient EuroPharma Co., Ltd. | 6.64 Billion TWD | 49.337% |
Center Laboratories, Inc. | 6.78 Billion TWD | 50.357% |
Tien Liang BioTech Co., Ltd. | 161.05 Million TWD | -1991.726% |
Orient Pharma Co., Ltd. | 892.18 Million TWD | -277.587% |
InnoPharmax Inc. | 48.64 Million TWD | -6824.638% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 320.99 Million TWD | -949.483% |
Excelsior Biopharma Inc. | 472.87 Million TWD | -612.403% |
DV Biomed Co., Ltd. | 765.87 Million TWD | -339.859% |
Foresee Pharmaceuticals Co., Ltd. | 616.93 Million TWD | -446.052% |
Handa Pharmaceuticals, Inc. | 280.88 Million TWD | -1099.357% |
UniPharma Co., Ltd. | 37.4 Million TWD | -8907.158% |
Anxo Pharmaceutical Co., Ltd. | 1.01 Billion TWD | -231.79% |
Alar Pharmaceuticals Inc. | 76.08 Million TWD | -4327.403% |
Winston Medical Supply Co., Ltd. | 373.87 Million TWD | -801.041% |
Mercury Biopharmaceutical Corporation | 49.72 Million TWD | -6675.34% |
Bioray Biotech Co., Ltd | 108.75 Million TWD | -2997.66% |
TSH Biopharm Corporation Limited | 133.62 Million TWD | -2421.042% |